DCF — ST. MARYS MEDICAL CENTER
Enterprise Value: $-172.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-172.4M
Enterprise Value
$-57.7M
PV of Cash Flows
$-114.7M
PV of Terminal Value
$-184.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $200.8M | $-9.0M | -5.0% | $-17.5M | $-15.9M |
| Year 2 | $206.8M | $-7.2M | -4.0% | $-16.0M | $-13.2M |
| Year 3 | $213.0M | $-5.3M | -3.0% | $-14.3M | $-10.8M |
| Year 4 | $219.4M | $-4.4M | -2.0% | $-13.7M | $-9.3M |
| Year 5 | $226.0M | $-4.0M | -2.0% | $-13.5M | $-8.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-172.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$195.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5